Valerio Therapeutics S.A.

Direct answer

Valerio Therapeutics S.A. is publicly traded on PAR under the ticker ALVIO.PA.

Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their...

Can you invest in Valerio Therapeutics S.A.?

Yes. Valerio Therapeutics S.A. is publicly traded on PAR under the ticker ALVIO.PA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Valerio Therapeutics S.A.

Detailed equity research is provided by MarketSnap.